Autoimmune hepatitis (AIH) is characterized by inflammatory liver histology, circulating non-organ-specific autoantibodies, and increased levels of immunoglobulin (Ig) G in the absence of a known etiology.
Requisites |
Diagnostic Criteria |
|
Definite |
Probable |
|
No genetic liver disease |
Normal alpha1 antitrypsin phenotype Normal serum ceruloplasmin, iron, and ferritin levels |
Partial alpha1 antitrypsin deficiency Nonspecific serum copper, ceruloplasmin, iron, and/or ferritin abnormalities |
No active viral infection |
No markers of current infection with hepatitis A, B, and C viruses |
No markers of current infection with hepatitis A, B, and C viruses |
No toxic or alcohol injury |
Daily alcohol < 25 g/d and no recent use of hepatotoxic drugs |
Daily alcohol < 50 g/d and no recent use of hepatotoxic drugs |
Laboratory features |
Predominant serum aminotransferase abnormality Globulin, gamma-globulin or immunoglobulin G level >/= 1.5 times normal |
Predominant serum aminotransferase abnormality Hypergammaglobulinemia of any degree |
Autoantibodies |
ANA, SMA, or anti-LKM1 >/= 1:80 in adults and >/=1:20 in children; no AMA |
ANA, SMA, or anti-LKM1 >/= 1:40 in adults or other autoantibodies* |
Histologic findings |
Interface hepatitis No biliary lesions, granulomas, or prominent changes suggestive of another disease |
Interface hepatitis No biliary lesions, granulomas, or prominent changes suggestive of another disease |
Abbreviation: AMA, antimitochondrial antibodies.
*Includes perinuclear anti-neutrophil cytoplasmic antibodies and the not generally available antibodies to soluble liver antigen/liver pancreas, actin, liver cytosol type 1, and asialoglycoprotein receptor.
Diagnostic Scoring System for Atypical Autoimmune Hepatitis in Adults
Category | Factor | Score |
Gender | Female | +2 |
Alk Phos:AST (or ALT) ratio | >3 <1.5 |
-2 +2 |
Gamma-globulin or IgG (times above upper limit of normal) | >2.0 1.5-2.0 1.0-1.5 <1.0 |
+3 +2 +1 0 |
ANA, SMA, or anti-LKM1 titers | >1:80 1:80 1:40 <1:40 |
+3 +2 +1 0 |
AMA | Positive | -4 |
Viral markers of active infection | Positive Negative |
-3 +3 |
Hepatotoxic drugs | Yes No |
-4 +1 |
Alcohol | <25 g/d >60 g/d |
+2 -2 |
Concurrent immune disease | Any nonhepatic disease of an immune nature | +2 |
Other autoantibodies* | Anti-SLA/LP, actin, LC1, pANCA | +2 |
Histologic features | Interface hepatitis Plasma cells Rosettes None of above Biliary changes Atypical features |
+3 +1 +1 -5 -3 -3 |
HLA | DR3 or DR4 | +1 |
Treatment response | Remission alone Remission with relapse |
+2 +3 |
Pretreatment score Definite diagnosis Probable diagnosis Posttreatment score Definite diagnosis Probable diagnosis |
>15 10-15 >17 |
Abbreviations: Alk phos, serum alkaline phosphatase level; AST, serum aspartate aminotransferase level; ALT, serum alanine aminotransferase level; IgG, serum immunoglobulin G level; AMA, antimitochondrial antibodies; HLA, human leukocyte antigen.
References:
- Czaja AJ, Freese DK; American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002 Aug;36(2):479-97 [Medline]
- Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde KH, Zeniya M, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999 Nov;31(5):929-38 [Medline]
Created: Feb 18, 2006